These advancements position microneedle technology as a transformative approach for delivering GLP-1 receptor agonists, offering the potential to improve therapeutic adherence, minimize systemic side effects, and support decentralized care models for diabetes management [43]
Steady Delivery: A transdermal patch could deliver the medication slowly and continuously over time, which might potentially reduce the intensity of side effects like nausea that can occur with a weekly bolus injection
Conclusion Active GLP-1 is a gut hormone derived as a result of proglucagon processing 1,2
Case report: Lifestyle changes and probiotic supplementation for improving longstanding type 2 diabetes in a male undergoing testosterone replacement therapy
With semaglutide (Wegovy), two missed doses may require restarting the full titration from the lowest dose
Stanford Health recommends avoiding greasy, spicy, highly seasoned, or overly sweet foods, and to not gorge on large, infrequent meals